title: [On the clinical usefulness of a few sugar antigens and a galactosyl-transferase].
abstract: Using human cultured cell lines or lymphocytes, two kinds of murine- and one human-monoclonal antibodies were produced, respectively and their clinical usefulness were investigated, and the possibility of galactosyl-transferase as a new tumor maker was also discussed. (1) A murine monoclonal antibody MSN-1, which was raised against human endometrial cancer cell line and recognized blood type sugar chain Leb, reacted with about 85% of endometrial cancer tissues, indicating that useful clinical information may be obtained by applying MSN-1 to immunohistochemistry and flow cytometry. (2) A new assay system using two murine monoclonal antibodies MA54 and MA61, which were raised against human lung cancer cell line and reacted with mucin sugar residues, revealed 76% positive rate in ovarian cancer patients, especially 82% in mucinous cystadenocarcinoma, indicating the clinical effectiveness as a new tumor maker compensating for the drawbacks of CA-125. (3) Galactosyl-transferase isozyme GT-2 was analyzed by the assay system using a newly produced monoclonal antibody. GT-2 was positive in 74% of ovarian cancers, especially in 89% of meso-nephroid cancer, indicating that GT-2 could be a useful tumor maker in ovarian tumors. (4) Human monoclonal antibody, which recognized "type 1 sugar chain" or iso-paragloboside, reacted about one half of endometrial cancer tissues. The production of human monoclonal antibody may contribute to the cancer imaging and the missile therapy.
authors.affiliation: Department of Obstetrics & Gynecology, School of Medicine, Keio University.
authors.forename: S
authors.initials: S
authors.lastname: Nozawa
authors.forename: S
authors.initials: S
authors.lastname: Izumi
authors.forename: M
authors.initials: M
authors.lastname: Sakayori
authors.forename: S
authors.initials: S
authors.lastname: Narisawa
authors.forename: K
authors.initials: K
authors.lastname: Kojima
authors.forename: R
authors.initials: R
authors.lastname: Iizuka
authors.forename: M
authors.initials: M
authors.lastname: Iwamori
authors.forename: Y
authors.initials: Y
authors.lastname: Nagai
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D014408:Biomarkers, Tumor / Q000032:analysis*; D005260:Female; D005434:Flow Cytometry; D005700:Galactosyltransferases / Q000032:analysis*; D006801:Humans; D007124:Immunoenzyme Techniques; D008175:Lung Neoplasms / Q000276:immunology; D051379:Mice; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000276:immunology; D014407:Tumor Cells, Cultured; D014594:Uterine Neoplasms / Q000175:diagnosis* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; D005700:Galactosyltransferases; C063054:galactosylxylosylprotein 3-beta-galactosyltransferase